elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38389326-B135ACE7-FA5A-4443-BEDD-2E4DA6BD0645
Q38389326-B135ACE7-FA5A-4443-BEDD-2E4DA6BD0645
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38389326-B135ACE7-FA5A-4443-BEDD-2E4DA6BD0645
Rationale for combining immunotherapy with chemotherapy.
P2860
Q38389326-B135ACE7-FA5A-4443-BEDD-2E4DA6BD0645
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38389326-B135ACE7-FA5A-4443-BEDD-2E4DA6BD0645
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
51d22f9409c4ee32a6e858e26ad33f0653f6754b
P2860
Anti-programmed death-1 and anti-programmed death-ligand 1 antibodies in cancer therapy.